In-situ Hybridization Market Trends

In-situ Hybridization Market Trends

The growing prevalence of chronic diseases is a significant driver for in-situ hybridization industry. ISH allows for the visualization of specific genetic markers, mutations, and gene expression patterns associated with different types of chronic diseases.
 

• Cancer is one of the leading causes of morbidity and mortality globally, with a rising incidence in many countries. For instance, according to Wiley, in 2024, there are approximately 2,001,140 new cancer cases and it is the equivalent of about 5480 diagnoses each day in the U.S.
   
• ISH helps in early detection by cancer biomarkers and identifying genetic abnormalities, such as gene amplifications or translocations, which are critical for early intervention and treatment planning.
   
• Similarly, neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and others are becoming more prevalent with aging populations. ISH helps researchers and clinicians understand gene expression changes, protein distribution, and cellular interactions in the brain.
   
• ISH is also used to study gene expression patterns in heart tissues affected by CVDs, providing insights into disease mechanisms. It helps identify molecular targets for drug development and assesses the efficacy of cardiovascular therapies, thereby escalating the growth of the market.